Merck’s drug for bacterial infection leads to fatal diarrhea
merck
December, 24 2024
(Web Desk) Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI).

CDI is generally caused by prolonged use of antibiotics, and can lead to potentially fatal diarrhea and inflammation of the colon.

The drugmaker did not immediately comment on the matter.

Zinplava will be discontinued on Jan. 31, the regulator s website showed, but no reason was cited for the decision.

          
Must Read
Image
New electric bus service in Lahore: Routes and details
February, 21 2025
Image
Apple launches iPhone 16e: Features and price in Pakistan
February, 21 2025
Image
Pakistan’s run rate significantly lower than Bangladesh’s ahead of India clash
February, 20 2025
Image
How to apply for the Asaan Karobaar scheme: A step-by-step guide
February, 20 2025